115 related articles for article (PubMed ID: 32156471)
1. Decreased expression of IGFBP6 correlates with poor survival in colorectal cancer patients.
Zhao C; Zhu X; Wang G; Wang W; Ju S; Wang X
Pathol Res Pract; 2020 May; 216(5):152909. PubMed ID: 32156471
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Model for Studying of the Role of IGFBP6 Gene in Breast Cancer Metastasizing.
Nikulin SV; Raigorodskaya MP; Poloznikov AA; Zakharova GS; Schumacher U; Wicklein D; Stürken C; Riecken K; Fomicheva KA; Alekseev BY; Shkurnikov MY
Bull Exp Biol Med; 2018 Mar; 164(5):688-692. PubMed ID: 29582205
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
8. Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.
Huang D; Lu W; Zou S; Wang H; Jiang Y; Zhang X; Li P; Songyang Z; Wang L; Wang J; Huang J; Fang L
Cancer Sci; 2017 Jul; 108(7):1293-1302. PubMed ID: 28417530
[TBL] [Abstract][Full Text] [Related]
9. GRIM-19 expression is a potent prognostic marker in colorectal cancer.
Hao M; Shu Z; Sun H; Sun R; Wang Y; Liu T; Ji D; Cong X
Hum Pathol; 2015 Dec; 46(12):1815-20. PubMed ID: 26363526
[TBL] [Abstract][Full Text] [Related]
10. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
11. Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
Wang X; Chen J; Wang J; Yu F; Zhao S; Zhang Y; Tang H; Peng Z
BMC Cancer; 2016 Jul; 16():383. PubMed ID: 27378469
[TBL] [Abstract][Full Text] [Related]
12. Correlation of IGFBP-6 expression with apoptosis and migration of colorectal carcinoma cells.
Qiu F; Gao W; Wang B
Cancer Biomark; 2018; 21(4):893-898. PubMed ID: 29439316
[TBL] [Abstract][Full Text] [Related]
13. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
14. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
17. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
18. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
20. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]